PHASE III TRIAL OF BEVACIZUMAB ADDED TO STANDARD RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA: MATURE PROGRESSION-FREE SURVIVAL AND PRELIMINARY OVERALL SURVIVAL RESULTS IN AVAGLIO

被引：0
|
作者：
Chinot, Olivier [1 ]
Wick, Wolfgang [2 ]
Mason, Warren [3 ]
Henriksson, Roger [4 ]
Saran, Frank [5 ]
Nishikawa, Ryo [6 ]
Hilton, Magalie [7 ]
Abrey, Lauren [7 ]
Cloughesy, Timothy [8 ]
机构：
[1] Aix Marseille Univ, AP HM, Marseille, France
[2] Univ Heidelberg Hosp, Heidelberg, Germany
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Royal Marsden NHS Fdn Trust, Surrey, England
[6] Saitama Med Univ, Saitama, Japan
[7] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[8] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [41] MRI T2 RELAXIVITY IN THE PREDICTION OF PROGRESSION-FREE SURVIVAL IN NEWLY-DIAGNOSED GLIOBLASTOMA: WHOLE BRAIN MEASUREMENTS AND DEEP LEARNING
    Rulseh, Aaron
    Vymazal, Josef
    [J]. NEURO-ONCOLOGY, 2022, 24 : 180 - 180
  • [42] Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
    van den Bent, Martin J.
    Carpentier, Antoine F.
    Brandes, Alba A.
    Sanson, Marc
    Taphoorn, Martin J. B.
    Bernsen, Hans J. J. A.
    Frenay, Marc
    Tijssen, Cees C.
    Grisold, Wolfgang
    Sipos, Laslo
    Haaxma-Reiche, Hanny
    Kros, Johannes M.
    van Kouwenhoven, Mathilde C. M.
    Vecht, Charles J.
    Allgeier, Anouk
    Lacombe, Denis
    Gorlia, Thierry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2715 - 2722
  • [43] Mature results of a phase I/IIA trial of the integrin inhibitor cilengitide (EMD121974) added to standard concomitant and adjuvant temozolomide and radiotherapy (TMZ/RT) for newly diagnosed glioblastoma (GBM)
    Stupp, Roger
    Goldbrunner, Roland
    Neyns, Bart
    Schlegel, Uwe
    Clement, Paul
    Grabenbauer, Gerhard
    Hegi, Monika
    Nippgen, Johannes
    Picard, Martin
    Weller, Michael
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 517 - 517
  • [44] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Wei, Kuo-Chen
    Hsu, Peng-Wei
    Tsai, Hong-Chieh
    Lin, Ya-Jui
    Chen, Ko-Ting
    Toh, Cheng-Hong
    Huang, Hui-Lin
    Jung, Shih-Ming
    Tseng, Chen-Kan
    Ke, Yu-Xiong
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Kuo-Chen Wei
    Peng-Wei Hsu
    Hong-Chieh Tsai
    Ya-Jui Lin
    Ko-Ting Chen
    Cheng-Hong Toh
    Hui-Lin Huang
    Shih-Ming Jung
    Chen-Kan Tseng
    Yu-Xiong Ke
    [J]. Scientific Reports, 11
  • [46] Effect of Zinc Sulfate on Overall Survival and Progression-Free Survival in Patients with Glioblastoma Multiforme, a Phase II Study
    Ahmadloo, Niloofar
    Kameli, Parisa
    Ansari, Mansour
    Mosalaei, Ahmad
    Omidvari, Shapour
    Nasrollahi, Hamid
    Hamedi, Seyed Hassan
    Mohammadianpanah, Mohammad
    [J]. MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (01) : 113 - 118
  • [47] Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Peter G. Zaki
    Sanjeev Herr
    Matthew J. Shepard
    [J]. Journal of Neuro-Oncology, 2024, 167 : 363 - 364
  • [48] Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Zaki, Peter G.
    Herr, Sanjeev
    Shepard, Matthew J.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2024, 167 (02) : 363 - 364
  • [49] ICON7: Final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer
    Oza, A. M.
    Perren, T. J.
    Swart, A. M.
    Schroeder, W.
    Pujade-Lauraine, E.
    Havsteen, H.
    Beale, P.
    Cervantes, A. M.
    Embleton, A. C.
    Parmar, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S4 - S4
  • [50] Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study
    Nicholas, M. K.
    Lucas, R. V.
    Arzbaecher, J.
    Paleologos, N.
    Krouwer, H.
    Malkin, M.
    Omar, A.
    Vick, N. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345